
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
Case History: 60-year-old male presents with behavioral changes for 2 months in bipolar disorder.
Case History: A 60-year-old male presents with complaints of behavioral changes for 2 months in bipolar disorder.

